Mitochondrial, Metabolic and Genotoxic Effects of Antiretroviral Nucleoside Reverse-Transcriptase Inhibitors

E-ISSN： 1875-6018|5|3|273-292

ISSN： 1871-5214

Source： Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol.5, Iss.3, 2006-07, pp. : 273-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Emerging Roles of Non-Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Therapy

By Moyle G.

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 19-26

Adis International

Access to resources Recommend Favorite

Cost Assessment of Antiretroviral Drugs Used in the Treatment of Patients with HIV Infection: Focus on Non-Nucleoside Reverse Transcriptase Inhibitors

By Sabbatani S.

Clinical Drug Investigation, Vol. 22, Iss. 4, 2002-01 ,pp. : 253-262

Adis International

Access to resources Recommend Favorite

From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir

By Curran Adrian Ribera Esteban

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 389-406

Informa Healthcare

Access to resources Recommend Favorite

Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA

By Koczor Christopher A Lewis William

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1493-1504

Informa Healthcare

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite